SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference

SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference is organized by SMi Group Ltd. and will be held from May 09 - 10, 2022 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

Who Should Attend:
• Head of Occupational hygiene
• Head of Industrial hygiene
• Head of Containment
• Head of Corporate Toxicology
• Head of Validation
• Director of Operation Quality
• Director of EHS
• Director of Drug Safety Evaluation
• Industrial Engineer
• Validation Expert
• Manufacturing Specialist
• QA Specialist/Manager
• Scale-up Operations Manager

Description:
HPAPI Containment and Facility Design For Successful Exposure Control
The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along with the increase in associated toxicities, are driving requirements for more effective containment solutions and much-needed guidelines to ensure worker safety.

The conference will encompass the critical topics including risk assessment, occupational toxicology, engineering controls for containment, facility design, and the impact of pharmaceutical manufacture on the environment.

This two-day agenda offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Expand your community and explore the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading pharmaceutical and biotechnology companies.

Benefits of Attending the HPAPI Conference:
• Dissect comprehensive hazard assessment and occupational exposure limit determination
• Evaluate the increasing trend toward more potent therapies and the consequences of the changing face of pharma
• Assess engineering containment controls, from isolators and barriers to fully automated lines
• Explore the employment of cleaning validation, organisational controls, and facility as key measure to tackle cross contamination